Upper Tract Tumors - Results from #1040

REVIEW UroToday

Urothelial carcinoma of the urinary bladder in young adults: Presentation, clinical behavior and outcome - Abstract January 18, 2012

HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladder - Abstract January 16, 2012

Efficacy of instillations with chemotherapy or immunotherapy following endoscopic resection for upper tract urothelial carcinoma - Abstract January 13, 2012

Urothelial cancers: Using biology to improve outcomes - Abstract January 13, 2012

Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer - Abstract January 9, 2012

Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid - Abstract January 6, 2012

Update on chemotherapy in the treatment of urothelial carcinoma - Abstract January 6, 2012

Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma - Abstract January 4, 2012

Different HER2 protein expression profiles aid in the histologic differential diagnosis between urothelial carcinoma in situ (CIS) and non-CIS conditions (dysplasia and reactive atypia) of the urinary bladder mucosa - Abstract December 19, 2011

Metachronous urothelial cancer in bilateral upper urinary tracts and bladder associated with hereditary nonpolyposis colorectal cancer - Abstract December 16, 2011

Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a - Abstract November 29, 2011

Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma - Abstract November 11, 2011

High-grade invasive urothelial carcinoma with focal plasmacytoid differentiation successfully treated by transurethral resection followed by chemoradiotherapy - Abstract November 9, 2011

Urothelial carcinoma of the bladder: Definition, treatment and future efforts - Abstract November 2, 2011

hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas - Abstract November 2, 2011

Gemcitabine or gemcitabine plus oxaliplatin in the first-line treatment of patients with advanced transitional cell carcinoma of the urothelium unfit for cisplatin-based chemotherapy: A randomized phase 2 study of the French Genitourinary Tumor Group (GET November 2, 2011

Tissue engineering potential of urothelial cells from diseased bladders - Abstract October 17, 2011

Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma - Abstract October 12, 2011

Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis - Abstract October 10, 2011

Upper urinary tract transitional cell carcinoma: Location is not correlated with prognosis - Abstract October 3, 2011

Page 53 of 57